X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3333) 3333
Book Chapter (151) 151
Dissertation (25) 25
Paper (3) 3
Publication (3) 3
Book / eBook (2) 2
Journal / eJournal (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1980) 1980
life sciences & biomedicine (1966) 1966
humans (1756) 1756
atypical antipsychotics (1719) 1719
schizophrenia (1250) 1250
psychiatry (1229) 1229
male (1195) 1195
antipsychotic agents - therapeutic use (1121) 1121
female (978) 978
pharmacology & pharmacy (852) 852
adult (813) 813
antipsychotic agents - adverse effects (745) 745
neurosciences & neurology (723) 723
schizophrenia - drug therapy (721) 721
atypical antipsychotic (705) 705
middle aged (639) 639
neurosciences (566) 566
olanzapine (488) 488
clinical neurology (439) 439
antipsychotic drugs (421) 421
treatment outcome (404) 404
risperidone (401) 401
animals (398) 398
antipsychotic agents - pharmacology (391) 391
clozapine (362) 362
aged (339) 339
adolescent (322) 322
antipsychotic agents - administration & dosage (319) 319
bipolar disorder (293) 293
drug therapy (281) 281
quetiapine (279) 279
risperidone - therapeutic use (277) 277
rats (243) 243
dose-response relationship, drug (242) 242
psychotic disorders - drug therapy (234) 234
quetiapine fumarate (233) 233
psychotropic drugs (222) 222
atypical (220) 220
psychiatric status rating scales (207) 207
aripiprazole (201) 201
benzodiazepines - therapeutic use (196) 196
dopamine (191) 191
bipolar disorder - drug therapy (190) 190
neuroleptics (189) 189
analysis (183) 183
benzodiazepines (174) 174
double-blind method (173) 173
retrospective studies (172) 172
risperidone - adverse effects (172) 172
young adult (172) 172
schizophrenic psychology (168) 168
psychosis (166) 166
antipsychotics (165) 165
dibenzothiazepines - therapeutic use (160) 160
risk factors (154) 154
drugs (152) 152
mental disorders (152) 152
antidepressants (149) 149
drug therapy, combination (145) 145
comorbidity (144) 144
piperazines - therapeutic use (142) 142
atypical neuroleptics (140) 140
ptsd (140) 140
randomized controlled trials as topic (140) 140
psychology (139) 139
clozapine - pharmacology (138) 138
antipsychotic (135) 135
time factors (135) 135
general & internal medicine (134) 134
social sciences (134) 134
medicine, general & internal (133) 133
depression (131) 131
serotonin (131) 131
care and treatment (129) 129
clozapine - therapeutic use (126) 126
atypical antipsychotic drugs (118) 118
benzodiazepines - adverse effects (116) 116
medicine & public health (114) 114
haloperidol (113) 113
rats, sprague-dawley (113) 113
weight gain (112) 112
pirenzepine - analogs & derivatives (110) 110
child (109) 109
dementia (107) 107
psychopharmacology (105) 105
diabetes (103) 103
aged, 80 and over (102) 102
antipsychotic agents (102) 102
ziprasidone (102) 102
side effects (101) 101
dibenzothiazepines - adverse effects (99) 99
clinical trials (96) 96
piperazines - adverse effects (96) 96
internal medicine (95) 95
research (95) 95
antidepressive agents - therapeutic use (94) 94
neurology (93) 93
follow-up studies (92) 92
schizophrenia - diagnosis (91) 91
quinolones - therapeutic use (90) 90
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3215) 3215
French (71) 71
German (69) 69
Italian (41) 41
Spanish (41) 41
Turkish (33) 33
Portuguese (20) 20
Japanese (18) 18
Russian (16) 16
Czech (15) 15
Dutch (11) 11
Polish (9) 9
Korean (5) 5
Persian (3) 3
Slovak (3) 3
Chinese (2) 2
Croatian (2) 2
Hungarian (1) 1
Icelandic (1) 1
Norwegian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 05/2015, Volume 72, Issue 5, pp. 438 - 445
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2009, Volume 15, Issue 22, pp. 2535 - 2549
Despite a large number of neuroimaging studies in schizophrenia reporting subtle brain abnormalities, we do not know to what extent such abnormalities reflect the effects of antipsychotic treatment on brain structure... 
Neuroimaging | Antipsychotics | Typical | Atypical neuroleptics | MRI | Schizophrenia | Conventional | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Brain - drug effects | Antipsychotic Agents - therapeutic use | Humans | Brain - pathology | Magnetic Resonance Imaging - methods | Clinical Trials as Topic | Schizophrenia - pathology | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy
Journal Article
Journal Article
Journal of Affective Disorders, ISSN 0165-0327, 2006, Volume 98, Issue 3, pp. 247 - 252
..., [atypical antipsychotics (AA) and mood stabilizers (MS)], inducing metabolic syndrome (MetS). Methods 125 bipolar patients, diagnosed according to the DSM IV... 
Psychiatry | Mood stabilizers | Bipolar disorder | Atypical antipsychotics | Metabolic syndrome | Clinical Neurology | Neurosciences & Neurology |